Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1330137

registered interest
date	07/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Infrastructure: Iron and Steel
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how much UK-produced steel reinforcing bar was procured for Government-funded infrastructure projects in each of the last three years.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	11567
answer	answer is ministerial correction date of answer 10/06/2021 answer text <p>The Department for Business, Energy and Industrial Strategy (BEIS) collates and publishes annually information on how much steel is purchased for the Government’s major infrastructure projects in the previous financial year, including what proportion is produced in the UK. This year’s data was published on 19 May and can be found at: <a href="http://www.gov.uk/government/publications/steel-public-procurement-2021" target="_blank">www.gov.uk/government/publications/steel-public-procurement-2021</a>.</p><p> </p><p>The reported value of UK steel procured in 2019/20 for major public projects was £108m, a 33% increase on the previous year. BEIS will start collating data for 2020/21 in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/06/2021 14:28:51 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1281032

registered interest
date	27/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Vaccine Manufacturing and Innovation Centre: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 26 January 2021 to Question 141474, how many additional vaccine doses per month the expanded Vaccine Manufacturing Innovation Centre facility can produce as a result of the investment outlined in that Answer; and of which types of vaccine.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	144691
answer	answer is ministerial correction date of answer 01/02/2021 answer text <p>When fully operationally in 2022, the Vaccines Manufacturing and Innovation Centre (VMIC) will have several Good Manufacturing Process suites that will be able to accommodate a range of production scale capabilities. For pandemic response, the VMIC will be able to make up to 70 million doses of a vaccine within a 6-month timeframe. This is a significant increase to the VMIC’s originally anticipated capacity.</p><p> </p><p>The VMIC has been designed to be a flexible manufacturing facility and will be able to manufacture a range of vaccine types, such as messenger RNA, viral vector, or protein sub-unit.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 01/02/2021 16:13:48 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1280122

registered interest
date	25/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Vaccine Manufacturing and Innovation Centre
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, when the expansion of the VMIC facility is planned to be completed.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	142941
answer	answer is ministerial correction date of answer 28/01/2021 answer text <p>The Vaccines Manufacturing and Innovation Centre (VMIC) should be partially open in summer 2021, with the facility fully operational in 2022. The VMIC is working towards having fill-finish capability at the end of 2021. The objective remains to accelerate the readiness of the VMIC by a year and it is on track to achieve this, but it is also important to remember this is a complex project being delivered in unprecedented times.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/01/2021 17:21:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1280124

registered interest
date	25/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the (a) design, (b) bio-engineering and (c) manufacture of vaccines capable of responding to the 501 and 484 variants of covid-19 has commenced.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	142942
answer	answer is ministerial correction date of answer 28/01/2021 answer text <p>The Government is currently undertaking its own laboratory work as a priority to better understand the impact of the new Covid-19 variants on the vaccines currently in deployment, in particular the risk of vaccine resistance. We maintain close contact with vaccine developers to understand their own studies as to the efficacy of their vaccines on variants and the impact on current supply chain arrangements for their manufacture.</p><p> </p><p>We continue to take a portfolio-based approach that monitors the landscape of Covid-19 vaccine development and we remain confident that the three vaccines (Pfizer/BioNTech, Oxford University/AstraZeneca, and Moderna) that we have purchased, which have been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA), will continue to be effective against the virus.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/01/2021 17:19:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty

1280125

registered interest
date	25/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, when vaccines capable of responding to the 501 and 484 variants of covid-19 will be available for use in the general population.
tabling member constituency	Cardiff South and Penarth
tabling member printed	Stephen Doughty
uin	142943
answer	answer is ministerial correction date of answer 28/01/2021 answer text <p>The Government is currently undertaking its own laboratory work as a priority to better understand the impact of the new Covid-19 variants on the vaccines currently in deployment, in particular the risk of vaccine resistance. We maintain close contact with vaccine developers to understand their own studies as to the efficacy of their vaccines on variants and the impact on current supply chain arrangements for their manufacture.</p><p> </p><p>We continue to take a portfolio-based approach that monitors the landscape of Covid-19 vaccine development and we remain confident that the three vaccines (Pfizer/BioNTech, Oxford University/AstraZeneca, and Moderna) that we have purchased, which have been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA), will continue to be effective against the virus.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/01/2021 17:17:49 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4264 label Biography information for Stephen Doughty